Sokol Haxhinasto

Advisor
Molecular Mechanisms Regulating Synergistic Activation of B Lymphocytes by the B Cell Antigen Receptor and CD40
Biography

Haxhinasto SA, Bishop GA. Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation. J Biol Chem. 2004 Jan 23;279(4):2575 82. Epub 2003 Nov 6. PubMed PMID: 14604983.

Bishop GA, Haxhinasto SA, Stunz LL, Hostager BS. Antigen-specific B-lymphocyte activation. Crit Rev Immunol. 2003;23(3):149-97. Review. PubMed PMID: 14584878.

Haxhinasto SA, Bishop GA. A novel interaction between protein kinase D and TNF receptor associated factor molecules regulates B cell receptor-CD40 synergy. J Immunol. 2003 Nov 1;171(9):4655-62. PubMed PMID: 14568940.

Hostager BS, Haxhinasto SA, Rowland SL, Bishop GA. Tumor necrosis factor receptor associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J Biol Chem. 2003 Nov 14;278(46):45382-90. Epub 2003 Sep 4. PubMed PMID: 12958312.

Haxhinasto SA, Hostager BS, Bishop GA. Cutting edge: molecular mechanisms of synergy between CD40 and the B cell antigen receptor: role for TNF receptor-associated factor 2 in receptor interaction. J Immunol. 2002 Aug 1;169(3):1145-9. PubMed PMID: 12133933.

Associate Director
Immunology
Regeneron
Sokol Haxhinasto